Efficacy and tolerability of a 12-week combination chemotherapy followed by lomustine consolidation treatment in canine B- and T-cell lymphoma

Table 2 Summary of treatment outcome

	All dogs (n-144)	Dogs with B-cell lymphoma (n = 97)	Dogs with T-cell lymphoma (n = 34)
Response to treatment
CR	104 (72.2%)	75 (77.3%)	23 (67.6%)
PR	16 (11.1%)	9 ( 9.3%)	4 (11.8%)
SD + PD	24 (16.7%)	13 (13.4%)	7 (20.6%)
Median remission duration for
CR (= DFI)	242d	263d	161d
CR + PR	240d	253d	161d
Median survival duration for
All dogs	291d	357d	210d
Dogs with CR	374d	436d	252d

CR complete remission, PR partial remission, SD stable disease, DFI disease free interval

ISSN: 1751-0147